Unlocking AMCP Format Version 5.0: Navigating updates and best practices for formulary dossiers
This engaging webinar will kick off with a presentation covering key revisions in the AMCP Format 5.0, followed by an insightful panel discussion. Watch now to learn about dossier updates timing, proactive sharing strategies, economic modeling best practices, and more. Don’t miss this opportunity to refine your dossier submissions with expert guidance.
Moderator: Jasmine Knight, PharmD, MS, Senior Director, Digital Solutions, Cencora
Panelists:
- Adam Hoye-Simek, PharmD, RPH, Chair, Format for Formulary Submissions Committee, AMCP
- Ken O'Day, PhD, MPA, Senior Director, Evidence Synthesis & Modeling, Cencora
- Ben Penley, PharmD, MS, Manager, Evidence Generation & Value Communications, Cencora
- Kimberly Ruiz, EdM, Senior Director, Evidence Generation & Value Communications, Cencora
What you’ll come away with:
- Understanding of the updates and revisions in the latest AMCP Format Version 5.0
- Best practices for creating dossiers that align with the new AMCP Format guidance
- Effective approaches to economic modeling with dossier submissions
- Strategies for digital therapeutics, leveraging real-world evidence, addressing health disparities, and optimizing clinical evidence in dossier content
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.